MedinCell Partner Teva Announces Successful Launch of UZEDY™
Euronext: MEDCL – Montpellier – France – August 2, 2023 – 10:00 p.m.
________________________________________________________________________________
Richard Francis, Chairman and Chief Executive Officer of Teva, and Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, commented on UZEDY’s U.S. launch and the development of the long-acting injectable (LAI) olanzapine during the presentation of results for the second quarter of 2023:
About UZEDY (commercialization launched in May 2023)
Richard Francis said(1):
“We are on track with our plans and are even slightly ahead of our market access strategy targets. We are very happy with the launch. »